English | 简体中文 | 繁體中文 | 한국어 | 日本語
Thursday, 17 March 2022, 18:00 HKT/SGT
Share:
    

Source: BBGI PCL
BBGI PCL (SET: BBGI) Debuts Shares on the SET March 17
Aiming to be a leading bio-product group with green innovation and sustainability

BANGKOK, Mar 17, 2022 - (ACN Newswire) - BBGI PCL (SET: BBGI), a leader in the biofuel energy industry and creator of health-promoting high-value bio-products (HVP) for health and well-being, debuted its shares on the Stock Exchange of Thailand today under the symbol BBGI. Executives and financial advisers are confident investors will respond enthusiastically due to the company's strong foundation as a market leader in bio-fuels and the HVP industry in ASEAN.

Mr. Kittiphong Limsuwannarot, Chief Executive Officer and President of BBGI, introduced shares on the SET for trading on March 17, 2022, under the symbol "BBGI". He expressed confidence in the company's business potential, based on its strong foundation as a leading producer and distributor of biofuels in Thailand with a 17-year experience, and major shareholders KSL and BCP, upstream and downstream business operators for ethanol and biodiesel products, supporting BBGI's flagship biofuels business, and providing synthetic biology (SynBio) technology for the manufacture of HVP products to meet consumer trends in Health and Well-being in ASEAN.

M.L. Thongmakut Thongyai, Chief Executive Officer of Krungthai Zmico Securities Co., Ltd., as financial adviser and lead underwriter, says BBGI has a solid expertise in biotechnology derived from an integrated biofuels operation dealing with both ethanol and biodiesel. Advanced production technologies are used to enhance cost management efficiency and spur growth, he says. The company builds on its expertise in a way that helps it become a leading operator of High Value Bio-products (HVP) in Health and Well-being, which is a high-growth market with good gross profit rates. As such BBGI can be considered a company with strong business potential and opportunity for growth, and its shares will doubtless be appreciated by investors.

Corporate Communications Department
BBGI Public Company Limited
Tel: +66 2335 8826
Email: corp.comm@bbgigroup.com
Visit BBGI PCL at https://www.bbgigroup.com/en

BBGI PCL Equity [SET: BBGI] [RIC: BBGI:BK] [BB: BBGI:TB]
Released for BBGI PCL by MT Multimedia Co Ltd
Yuttachai Paikonahok (Tle), T: +66 91 736 2866; E: yuttachai.p@mtmultimedia.com

Topic: Press release summary
Source: BBGI PCL

Sectors: Daily Finance, BioTech
https://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2026 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 

Latest Press Releases
Peer To Peer Network (OTC: PTOP) Targets Revenue Inflection Point with MOBICARD 1.8 Launch Expected Within 30 Days  
Apr 25, 2026 07:03 HKT/SGT
EQIBank expands global, regulated Banking-as-a-Service platform for cross-border banking across fiat and digital assets  
Apr 24, 2026 19:00 HKT/SGT
analytica Hanoi 2026 Makes Its Debut, Bringing the Global Science and Laboratory Platform to Northern Vietnam  
Apr 24, 2026 12:05 HKT/SGT
FastX Announces Its Launch, a New Generation Global Trading Exchange  
Apr 24, 2026 12:00 HKT/SGT
CMS (867.HK; 8A8.SG): NDA for the Seasonal Allergic Rhinitis Indication of Class 1 Innovative Drug MG-K10 Accepted in China  
Apr 23, 2026 22:00 HKT/SGT
Smart Lighting Expo and Lighting Fair conclude successfully  
Apr 23, 2026 19:33 HKT/SGT
Sisel International Appoints Pamela Ferry as General Manager of Australia and New Zealand to Support Regional Expansion  
Apr 23, 2026 19:00 HKT/SGT
FastX Launching, a New Generation Global Trading Exchange  
Apr 23, 2026 18:00 HKT/SGT
NEC Announces Strategic Collaboration with Anthropic Focused on Enterprise AI  
Thursday, April 23, 2026 4:46:00 PM
Fujitsu and Carnegie Mellon University launch joint center for Physical AI  
Thursday, April 23, 2026 4:19:00 PM
More Press release >>
 Events:
More events >>
Copyright © 2026 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575